Trial starts for full-spectrum cannabis drug as 1st patient enrolls
A Phase 2 clinical trial evaluating Avextra’s cannabis-based oral solution’s safety and efficacy in people with Parkinson’s disease…
Articles by Patricia Inácio, PhD
Lasting benefits of bemdaneprocel for Parkinson’s seen in Phase 1 trial
Bemdaneprocel, a novel stem cell-derived therapy being developed by Bluerock Therapeutics, maintained a favorable safety profile and good tolerability…
Tiny brain device tracks Parkinson’s effect on executive function
Neurosurgeons temporarily implanted a tiny device into the brains of three people with Parkinson’s disease to collect data on…
MJFF grant supports AI-driven Parkinson’s research
The Michael J. Fox Foundation (MJFF) has awarded a grant to Valo Health to support the development of…
Boosting TFE3 in Parkinson’s may be neuroprotective: Study
Boosting levels of a protein called TFE3 helped reduce nerve cell degeneration and improve motor function in a mouse model…
Tracers help ID reactive astrocytes in Parkinson’s brain
Two imaging markers can help pinpoint sites of brain inflammation in people with Parkinson’s disease, according to a study.
Sensors help assess Parkinson’s patients for apomorphine therapy
Wearable sensors that monitor motor symptoms like tremor can accurately assess eligibility of Parkinson’s disease patients for apomorphine pump…
Study to test nasal spray at restoring loss of smell in Parkinson’s
Cyrano Therapeutics is supporting an investigator-initiated clinical study that will evaluate CYR-064, its leading nasal candidate therapy, to restore…
Creative arts therapy found to ease anxiety in Parkinson’s in pilot study
Creative arts therapy, or an expressive therapeutic approach that engages people in various creative activities, can reduce anxiety in individuals…
Clinical advisory board launched to boost GT-02287 development
Gain Therapeutics has set up a clinical advisory board made up of leading Parkinson’s experts in genetics, biomarkers, and…